U.S. stock futures edged higher on Thursday as investors prepared for upcoming PPI inflation data following a turbulent session triggered by the release of the August consumer price index. Wall Street is keenly awaiting the August producer price index, with economists surveyed by Dow Jones predicting a 0.2% increase in both the headline and core readings, up from the previous month’s 0.1% and 0.0%, respectively. Additionally, initial jobless claims data for the week ending September 7 is expected to show a slight decrease to 225,000 from 227,000 the previous week.

On Thursday, European stocks surged, with tech and mining stocks leading the charge, rising by 2.69% and 2.87%, respectively. Investors are anticipating a 25-basis point rate cut from the European Central Bank (ECB), which would be the first reduction since June. Additionally, European markets are reacting to the latest U.S. consumer price index (CPI) report, which showed a 0.2% increase in consumer prices for August, bringing the annual inflation rate down to 2.5%, the lowest since February 2021

On Thursday, Asia-Pacific markets experienced an upswing, mirroring the positive momentum from Wall Street, which was driven by a rally in the tech sector. In Japan, the producer price index (PPI) for August increased by 2.5% year-on-year, falling short of the anticipated 2.8% and the 3% rise observed in July. Meanwhile, India is set to release its consumer price index (CPI) for August later today.

Economic Calendar

Earnings Calendar

Notable reports for Thursday before the bell include CAL, KR, LOVE, & SIG After the bell include ADBE, & RH.

News & Technicals’

Norfolk Southern has announced the immediate departure of CEO Alan Shaw, who will be replaced by the company’s finance chief, Mark George. Shaw’s exit follows an investigation by the railroad’s board into an allegedly inappropriate relationship with the company’s chief legal officer, Nabanita Nag. Mark George, who has been with Norfolk Southern as CFO for nearly five years, will step into the role of CEO.

Moderna has announced plans to reduce its expenses by $1.1 billion by 2027 as it navigates the downturn in its Covid-related business. The biotech company aims to secure approvals for 10 new products by 2027, signaling a strategic shift towards diversifying its portfolio. However, this transition involves deprioritizing certain parts of its pipeline, leading to the suspension or discontinuation of some projects.

China has issued a stern warning of retaliation in response to a U.S. bill that could lead to the closure of Hong Kong’s trade offices. The proposed legislation mandates the U.S. secretary of state to conduct annual reviews of the “privileges, exemptions, and immunities” granted to Hong Kong’s Economic and Trade Offices. Beijing has urged the U.S. to halt the progression of this act to avoid further straining China-U.S. relations and has vowed to take “strong and resolute countermeasures” if the bill is enacted.

Eli Lilly has announced a significant investment of $1.8 billion to enhance its manufacturing capabilities in Ireland, focusing on its newly approved Alzheimer’s drug and popular weight loss and diabetes treatments. The pharmaceutical giant plans to allocate $1 billion to expand its existing site in Limerick, aiming to boost the production of active ingredients, including those used in its Alzheimer’s treatment, Kisunla. Additionally, Eli Lilly will invest $800 million in expanding its facility in Kinsale, which began producing drugs last year to meet the growing demand for its diabetes and weight loss medications.

After the massive reversal yesterday can the bulls follow though with the upcoming PPI inflation data and Jobless claims report?  One thing for sure is with the tremendous volatility traders should be prepared for just about anything remembering about 50% of the companies will be in their blackout period by the end of this week, ending corporate buyback activity. 

Trade Wisely,

Doug